[Comparative determination by the double blind method of capuride, secobarbital and placebos in psychiatric patients].
D000328:Adult; D001714:Bipolar Disorder / Q000150:complications; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D010919:Placebos; D012559:Schizophrenia / Q000150:complications; D012631:Secobarbital / Q000627:therapeutic use*; D012890:Sleep / Q000187:drug effects; D007319:Sleep Initiation and Maintenance Disorders / Q000150:complications / Q000188:drug therapy*; D014508:Urea / Q000627:therapeutic use*
D006993:Hypnotics and Sedatives; D010919:Placebos; D012631:Secobarbital; D014508:Urea
Evaluation comparative à double insu du capuride du sécobarbital et du placebo chez le malade psychiatrique.